Cargando…

Risk of Intraepithelial Neoplasia Grade 3 or Worse (CIN3+) among Women Examined by a 5-Type HPV mRNA Test during 2003 and 2004, Followed through 2015

SIMPLE SUMMARY: Cervical cancer is the fourth most common cancer in women worldwide. Persistent high-risk human papillomavirus (HPV) can cause invasive cervical cancer through a series of precancerous lesions. Screening women with either cytology examinations or a test detecting HPV infection can pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rad, Amir, Sørbye, Sveinung Wergeland, Tiwari, Sweta, Løchen, Maja-Lisa, Skjeldestad, Finn Egil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296297/ https://www.ncbi.nlm.nih.gov/pubmed/37370716 http://dx.doi.org/10.3390/cancers15123106

Ejemplares similares

May Women with a Negative Co-Test at First Follow-Up Visit Return to 3-Year Screening after Treatment for Cervical Intraepithelial Neoplasia?
por: Skjeldestad, Finn Egil, et al.
Publicado: (2023)

13-Type HPV DNA Test versus 5-Type HPV mRNA Test in Triage of Women Aged 25–33 Years with Minor Cytological Abnormalities–6 Years of Follow-Up
por: Rad, Amir, et al.
Publicado: (2023)

Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women—A cohort study
por: Westre, Bjørn, et al.
Publicado: (2019)

Risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) among women with HPV-test in 1990–1992, a 30-year follow-up study
por: Riibe, Marit Østlyngen, et al.
Publicado: (2021)

5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions
por: Westre, Bjørn, et al.
Publicado: (2016)

HPV mRNA Is More Specific than HPV DNA in Triage of Women with Minor Cervical Lesions
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2014)

HPV types in cervical cancer tissue in South Africa: A head-to-head comparison by mRNA and DNA tests
por: Rad, Amir, et al.
Publicado: (2017)

Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2016)

Underdiagnosis of cervical intraepithelial neoplasia (CIN) 2 or Worse Lesion in Women with a Previous Colposcopy-Guided Biopsy Showing CIN 1
por: Souza, Carlos André Scheler de, et al.
Publicado: (2017)

Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+ in young women with normal cervical cytology
por: Al-Shibli, Khalid, et al.
Publicado: (2022)

Performance of DNA methylation analysis in the detection of high-grade cervical intraepithelial neoplasia or worse (CIN3+): a cross-sectional study
por: Liu, Yuxiang, et al.
Publicado: (2023)

Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2–3: A narrative review
por: Desravines, Nerlyne, et al.
Publicado: (2020)

Pathways of IFN-alpha Activation in Patients with Cervical Intraepithelial Neoplasia (CIN)
por: Tirone, Nelson Ranieri, et al.
Publicado: (2021)

Plasma Protein Profiles Differ Between Women Diagnosed with Cervical Intraepithelial Neoplasia (CIN) 1 and 3
por: Piyathilake, Chandrika J., et al.
Publicado: (2007)

Acute anterior uveitis after topical interferon for conjunctival intraepithelial neoplasia (CIN)
por: Naravane, Ameay V., et al.
Publicado: (2021)

microRNAs’ differential regulations mediate the progress of Human Papillomavirus (HPV)-induced Cervical Intraepithelial Neoplasia (CIN)
por: Mo, Wenjuan, et al.
Publicado: (2015)

The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
por: Barrett, James E., et al.
Publicado: (2022)

Development and Validation of a Raman Spectroscopic Classification Model for Cervical Intraepithelial Neoplasia (CIN)
por: Traynor, Damien, et al.
Publicado: (2022)

Comparison of Expectant and Excisional/Ablative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in the Era of HPV Testing
por: Tjandraprawira, Kevin Dominique, et al.
Publicado: (2022)

Type distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia (CIN) stages 2 and 3 in Botswana
por: Ramogola-Masire, Doreen, et al.
Publicado: (2010)

Diagnostic Value of the Care™ HPV Test in Screening for Cervical Intraepithelial Neoplasia Grade 2 or Worse
por: Zarchi, Mojgan Karimi, et al.
Publicado: (2017)

High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling
por: Øvestad, Irene Tveiterås, et al.
Publicado: (2021)

Evaluation of the diagnostic performance of colposcopy in the diagnosis of histologic cervical intraepithelial neoplasia 2+ (CIN2+)
por: Dorji, Namkha, et al.
Publicado: (2022)

Pooled analysis of genome-wide association studies of cervical intraepithelial neoplasia 3 (CIN3) identifies a new susceptibility locus
por: Chen, Dan, et al.
Publicado: (2016)

The Role of Methylation of Host and/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions
por: Dovnik, Andraž, et al.
Publicado: (2023)

Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation
por: Vogelsang, Tilman L. R., et al.
Publicado: (2020)

Low-Grade Cervical Intraepithelial Neoplasia (CIN1) Evolution: Analysis of Opportunistic Preventive Vaccination Role
por: Gardella, Barbara, et al.
Publicado: (2023)

Dysbiotic Co-Factors in Cervical Cancer. How the Microbiome Influences the Development of Cervical Intraepithelial Neoplasia (CIN)
por: Finzer, Patrick, et al.
Publicado: (2023)

DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test
por: Herzog, Chiara, et al.
Publicado: (2022)

Diagnostic accuracy of cervical cancer screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) among women living with HIV: A systematic review and meta-analysis
por: Kelly, Helen, et al.
Publicado: (2022)

Predictors of Absent High-grade Cervical Intraepithelial Neoplasia (CIN) in Loop Electrosurgical Excision Procedure Specimens of Patients with Colposcopic Directed Biopsy-Confirmed High-Grade CIN
por: Poomtavorn, Yenrudee, et al.
Publicado: (2019)

Prevalence of human papillomavirus and subtype distribution in male partners of women with cervical intraepithelial neoplasia (CIN): a systematic review
por: Skoulakis, Anargyros, et al.
Publicado: (2019)

Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative
por: Koskimaa, Hanna-Mari, et al.
Publicado: (2015)

HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review
por: Derbie, Awoke, et al.
Publicado: (2020)

Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia
por: He, Yue, et al.
Publicado: (2017)

Cervical intraepithelial neoplasia 3, coinfected with HPV-16 and -18--case report.
por: Park, J. S., et al.
Publicado: (1993)

Triage of Women with Minor Cervical Lesions: Data Suggesting a “Test and Treat” Approach for HPV E6/E7 mRNA Testing
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2010)

Histological Characterization of Biliary Intraepithelial Neoplasia with respect to Pancreatic Intraepithelial Neoplasia
por: Sato, Yasunori, et al.
Publicado: (2014)

Genotype-specific methylation of HPV in cervical intraepithelial neoplasia
por: Hsu, Yaw-Wen, et al.
Publicado: (2017)

Risk of cervical intraepithelial neoplasia grade 2 or worse in women aged ≥ 69 referred to colposcopy due to an HPV-positive screening test
por: Booth, Berit B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cve7bfsd8apiq23vi6pulgr13f